Navigation Links
PhRMA Statement on Department of Homeland Security Efforts to Crack Down on Counterfeiting Crimes
Date:12/15/2010

WASHINGTON, Dec. 15, 2010 /PRNewswire-USNewswire/ -- Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John Castellani released the following statement regarding the Department of Homeland Security stepping up efforts to combat counterfeit drugs:

"The Department of Homeland Security's (DHS) decision to step up efforts to eliminate counterfeit medicines should not only be applauded but should also serve as a warning sign to criminals selling fake and harmful counterfeit pharmaceuticals to unsuspecting consumers.

"No country is immune to the worldwide counterfeit medicine threat. A growing web of criminal networks around the globe are selling dangerous counterfeit drugs to innocent victims – people who might think they're getting a good deal but in reality are receiving medicines that are fake, substandard and in some cases lethal. Make no mistake: criminals are not only targeting 'lifestyle' drugs but also vital medicines that treat cancer, diabetes, malaria and high blood pressure.

"The most common mechanism for counterfeit drugs to enter the U.S. drug supply is through purchases made on illegal online pharmacy sites that are operated by criminals in other countries with known counterfeiting problems. Cracking down on these illegal sites can help protect patient safety and help ensure that the closed U.S. drug supply system is not compromised.

"In most cases, criminals caught selling counterfeit medicines in the U.S. face lighter jail sentences and penalties than criminals selling illicit drugs such as heroin. For this reason, PhRMA will continue to advocate for stricter sentencing guidelines for counterfeiters – the average jail time for a counterfeiting crime is 3 years but we believe that 20 years is a better fit for such a potentially deadly crime.

"In the meantime, America's biopharmaceutical research companies will continue to work with key government agencies – such as DHS and the Food and Drug Administration – as well as members of Congress to help safeguard patient health and the U.S. drug supply system."

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country's leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $45.8 billion in 2009 in discovering and developing new medicines. Industry-wide research and investment reached a record $65.3 billion in 2009.

PhRMA Internet Address: http://www.phrma.org

For information on how innovative medicines save lives, visit: http://www.innovation.org

For information on the Partnership for Prescription Assistance, visit: http://www.pparx.org

For information on the danger of imported drugs, visit: http://www.buysafedrugs.info

For more information on public health emergencies, visit http://www.rxresponse.org


'/>"/>
SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PhRMA CEO John Castellani Responds to Mid-Term Election, Stresses Importance of Innovation to Help Grow Economy
2. PhRMA Statement on Health Care Reform
3. Pfizers Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts
4. PhRMA Honors Patient Advocates Ron and Raychel Bartek
5. Seven New Biopharmaceutical Research Companies Join PhRMAs Mission to Advance Medical Innovation
6. PhRMA Statement Supporting Fair Incentives for Biologics Innovation
7. PhRMA Statement on Senate Finance Committee Vote
8. Lilly Statement Regarding President Obamas Meeting With U.S. Business Leaders
9. AcelRx Pharmaceuticals Files Registration Statement for Proposed Initial Public Offering
10. ERT Files Shelf Registration Statement
11. Ambit Biosciences Files Registration Statement for Proposed Initial Public Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... 2016 Transparency Market Research has ... Insufficiency Market - Global Industry Analysis, Size, Share, Growth, ... the report, the exocrine pancreatic insufficiency market is anticipated ... to 2023 to reach US$2.85 Bn by 2023. ... by the deficiency of the exocrine pancreatic enzymes, causing ...
(Date:5/23/2016)... , May 23, 2016 ... Devices, Diagnostics and Monitoring, and Vision Care ... Which areas are going to grow at the fastest ... revenues to 2026, assessing data, trends, opportunities and prospects. ... charts, and graphs. Discover the most lucrative areas in ...
(Date:5/23/2016)... 2016 Non-invasive diagnostic test realizes ... diseases; ,Technology to be presented at Yissum’s booth, at ... Development Company of the Hebrew University of Jerusalem ... with Aurum Ventures MKI, the technology investment arm of ... diagnostic approach for early detection of multiple diseases by ...
Breaking Medicine Technology:
(Date:5/25/2016)... ... May 25, 2016 , ... The World Molecular Imaging Society ... Imaging.” The focus of ADDMI-IG will be geared towards how using molecular imaging ... Through ADDMI-IG WMIS will provide a platform for productive discussions about the implementation ...
(Date:5/25/2016)... ... May 25, 2016 , ... TransactRx announces the ... adjudication of medical service claims by Pharmacy Benefit Managers that were submitted by ... software. The TransactRx Cross Benefit Clearinghouse receives standard professional medical claims submitted from ...
(Date:5/25/2016)... ... 2016 , ... For more than fifty years, we've suffered whiplash as each new scientific study ... to the latest nutritional advice – advice that was supposed to keep us healthy and ... 3 American adults are considered to be overweight and more than 1 in 3 adults ...
(Date:5/25/2016)... ... , ... Consumer access to organic foods and grower access to food processers ... grain cereals and other plant-based foods, will introduce the first consumer product (a new ... by Hesco/Dakota Organic Products. , The transitional designation means the cereal was made using ...
(Date:5/24/2016)... ... , ... According to an article published May 11th on Fox ... the amount of calories they consumed by 25% experienced some interesting health benefits. This ... improved quality of life, and enhanced sexual function compared to the other group, which ...
Breaking Medicine News(10 mins):